These findings documented that diabetes promoted NADPH oxidase-derived ROS formation in mouse kidneys, which was suppressed by ferroptosis inhibitor Ferrostatin-1 treatment in diabetic mouse kidneys. Here, FMO5 is linked to diabetes mellitus.